Xi SC - Search Results

1

Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.

Chen WW, Gong KK, Yang LJ, Dai JJ, Zhang Q, Wang F, Li XL, Xi SC, Du J. Chen WW, et al. Among authors: xi sc. J Ethnopharmacol. 2021 Jan 30;265:113295. doi: 10.1016/j.jep.2020.113295. Epub 2020 Aug 22. J Ethnopharmacol. 2021. PMID: 32841701

2

Repression of YAP by NCTD disrupts NSCLC progression.

Guo J, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Li X, Xi S. Guo J, et al. Oncotarget. 2017 Jan 10;8(2):2307-2319. doi: 10.18632/oncotarget.13668. Oncotarget. 2017. PMID: 27903989 Free PMC article.

3

Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.

Du J, Chen W, Yang L, Dai J, Guo J, Wu Y, Gong K, Zhang J, Yu N, Xie Z, Xi S. Du J, et al. Sci Rep. 2017 May 15;7(1):1899. doi: 10.1038/s41598-017-02063-x. Sci Rep. 2017. PMID: 28507311 Free PMC article.

4

Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness.

Chen W, An J, Guo J, Wu Y, Yang L, Dai J, Gong K, Miao S, Xi S, Du J. Chen W, et al. Cancer Chemother Pharmacol. 2018 May;81(5):885-895. doi: 10.1007/s00280-018-3561-4. Epub 2018 Mar 15. Cancer Chemother Pharmacol. 2018. PMID: 29546459

5

Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma.

Gong K, Miao S, Yang L, Wu Y, Guo J, Chen W, Dai J, Du J, Xi S. Gong K, et al. Pharm Biol. 2020 Dec;58(1):1044-1054. doi: 10.1080/13880209.2020.1822420. Pharm Biol. 2020. PMID: 33027592 Free PMC article.

6

Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression.

Guo J, Wu Y, Du J, Yang L, Chen W, Gong K, Dai J, Miao S, Jin D, Xi S. Guo J, et al. Oncogenesis. 2018 Jun 13;7(6):49. doi: 10.1038/s41389-018-0054-6. Oncogenesis. 2018. PMID: 29904125 Free PMC article.

7

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.

Guo J, Jin D, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Miao S, Xi S. Guo J, et al. EBioMedicine. 2018 Sep;35:204-221. doi: 10.1016/j.ebiom.2018.08.001. Epub 2018 Aug 23. EBioMedicine. 2018. PMID: 30146342 Free PMC article. Retracted.

8

Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.

Du J, Chen W, Yang L, Dai J, Guo J, Wu Y, Gong K, Zhang J, Yu N, Xie Z, Xi S. Du J, et al. Sci Rep. 2020 Oct 22;10(1):18511. doi: 10.1038/s41598-020-74978-x. Sci Rep. 2020. PMID: 33093558 Free PMC article.

9

Retraction notice to 'The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells' [EBioMedicine 35 (2018) 204-221].

Guo J, Jin D, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Miao S, Xi S. Guo J, et al. EBioMedicine. 2021 Jan;63:103168. doi: 10.1016/j.ebiom.2020.103168. EBioMedicine. 2021. PMID: 33487222 Free PMC article. No abstract available.

10

Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.

Zhang M, Mathur A, Zhang Y, Xi S, Atay S, Hong JA, Datrice N, Upham T, Kemp CD, Ripley RT, Wiegand G, Avital I, Fetsch P, Mani H, Zlott D, Robey R, Bates SE, Li X, Rao M, Schrump DS. Zhang M, et al. Cancer Res. 2012 Aug 15;72(16):4178-92. doi: 10.1158/0008-5472.CAN-11-3983. Epub 2012 Jul 2. Cancer Res. 2012. PMID: 22751465 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page